Table 6.
Characteristics | First Tier, SBP 170–200 mm Hg, n = 18 |
Second Tier, SBP 140–170 mm Hg, n = 20 |
Third Tier, SBP 110–140 mm Hg, n = 22 |
---|---|---|---|
Treatment failure | 0 | 0 | 9 (41%) |
N (%) with SAE within 72 hrs | 0 | 1 (5%) | 3 (14%) |
N (%) with neurologic deterioration within 24 hrs | 1 (6%) | 2 (10%) | 4 (18%) |
N (%) with symptomatic hematoma expansion | 0 | 1 (5%) | 4 (18%) |
N (%) with asymptomatic hematoma expansion | 6 (33%) | 2 (10%) | 3 (14%) |
N (%) with in-hospital mortality | 2 (11%) | 1 (5%) | 1 (4 %) |
N (%) with 3-mo mortality | 3 (17%) | 2 (10%) | 5 (23%) |
1-mo favorable outcome, mRS 0–2 | 4 (3 missing) | 6 (3 missing) | 4 (2 missing) |
3-mo favorable outcome, mRS 0–2 | 8 (3 missing) | 9 (4 missing) | 7 (2 missing) |
SBP, systolic blood pressue; SAE, serious adverse event; mRS, modified Rankin score.